| Zacks Company Profile for Maravai LifeSciences Holdings, Inc. (MRVI : NSDQ) |
|
|
| |
| • Company Description |
| Maravai LifeSciences Holdings Inc. is a life sciences company providing products for the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company offer products and services in the fields of nucleic acid synthesis, bioprocess impurity detection and analysis, protein labeling and detection to biopharmaceutical, vaccine, diagnostics and cell and gene therapy companies. Maravai LifeSciences Holdings Inc. is based in SAN DIEGO, Calif.
Number of Employees: 570 |
|
|
| |
| • Price / Volume Information |
| Yesterday's Closing Price: $2.51 |
Daily Weekly Monthly
 |
| 20 Day Moving Average: 1,814,969 shares |
| Shares Outstanding: 254.66 (millions) |
| Market Capitalization: $639.20 (millions) |
| Beta: 0.28 |
| 52 Week High: $10.03 |
| 52 Week Low: $1.67 |
| Short Interest Ratio: |
| |
% Price Change |
% Price Change Relative to S&P 500 |
| 4 Week |
13.06% |
8.91% |
| 12 Week |
33.51% |
7.33% |
| Year To Date |
-53.94% |
-56.30% |
|
|
|
|
| |
| • Address & Contact Information |
| Street Address |
Phone / Fax |
Email Address |
Web URL |
10770 WATERIDGE CIRCLE SUITE 200
-
SAN DIEGO,CA 92121
USA |
ph: 858-546-0004
fax: - |
ir@maravai.com |
http://www.maravai.com |
|
|
| |
| • General Corporate Information |
Officers
William E. Martin, III - Chief Executive Officer
Robert Andrew Eckert - Chairman
Kevin Herde - Chief Financial Officer
Sean Cunningham - Director
Benjamin Daverman - Director
|
|
Peer Information
Maravai LifeSciences Holdings, Inc. (BJCT)
Maravai LifeSciences Holdings, Inc. (CADMQ)
Maravai LifeSciences Holdings, Inc. (APNO)
Maravai LifeSciences Holdings, Inc. (UPDC)
Maravai LifeSciences Holdings, Inc. (IMTIQ)
Maravai LifeSciences Holdings, Inc. (CYGN)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 56600D107
SIC: 2834
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/06/25
|
|
Share - Related Items
Shares Outstanding: 254.66
Most Recent Split Date: (:1)
Beta: 0.28
Market Capitalization: $639.20 (millions)
|
|
|
|
|
| |
| • EPS Information |
• Dividend Information |
| Analyst Coverage: No |
Dividend Yield: 0.00% |
| Current Fiscal Quarter EPS Consensus Estimate: $-0.08 |
Indicated Annual Dividend: $0.00 |
| Current Fiscal Year EPS Consensus Estimate: $-0.37 |
Payout Ratio: |
| Number of Estimates in the Fiscal Year Consensus: 4.00 |
Change In Payout Ratio: |
| Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
| Next EPS Report Date: 08/06/25 |
|
|
|
| |
